SIBI! EM BREVE O RIUFPA ESTARÁ LIBERADO! AGUARDEM!

Estatísticas para Optical coherence tomography and multifocal electroretinography of patients with advanced neovascular age related macular degeneration before, during, and after treatment with ranibizumab